Diabetes and tumor risk: a 23-year Danish national cohort study
Our findings provide population-level evidence that advances our understanding of the possible complex metabolic links between diabetes and tumor development. Further exploration of SNOMED-based tumor classifications in future studies may provide valuable knowledge on pathological differences and refine future tumor and cancer surveillance strategies in individuals with diabetes.
Authors
- Katja Christina Schielke (ORCID: https://orcid.org/0000-0002-4281-9626)
- Steffen Heegaard (ORCID: https://orcid.org/0000-0001-5906-7670)
- Caroline Schmidt Laugesen (ORCID: https://orcid.org/0000-0003-4279-8180)
- Jakob Grauslund (ORCID: https://orcid.org/0000-0001-5019-0736)
- TOKE BEK
- Frederik Nørregaard Pedersen (ORCID: https://orcid.org/0000-0003-3713-9949)
- Flemming Pociot (ORCID: https://orcid.org/0000-0003-3274-5448)
- Sören Möller (ORCID: https://orcid.org/0000-0003-0858-4269)
- Julie Christine Antvorskov (ORCID: https://orcid.org/0000-0003-2618-6301)
- Tine Dreier Bille
- Katja F. Skovbjerg
- Nis Andersen
- Jens Andresen
- Ryo Kawasaki
- Anne S. Thykjær Petersen
- Javad Hajar
- Lonny M. Stokholm
Institutions
- University of Copenhagen (DK)
- Steno Diabetes Centers (DK)
- University of Southern Denmark (DK)
- Roskilde Sygehus (DK)
- Aalborg University Hospital (DK)
- Odense University Hospital (DK)
- Glostrup Hospital (DK)
- Aarhus University Hospital (DK)
- Rigshospitalet (DK)
- Danish Cardiovascular Research Academy (DK)
- Zealand University Hospital (DK)
- Osaka University Hospital (JP)
- Osaka City University Hospital (JP)
- IT University of Copenhagen (DK)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2026-01-07
- DOI
- https://doi.org/10.3389/fendo.2025.1725065
- Primary Topic
- Metabolism, Diabetes, and Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Steno Diabetes Center Copenhagen